23 Oct HealthLeaders: After stalling for months, HHS plans to accelerate 340B changes
“Since taking office last year, the Trump administration has repeatedly delayed implementation of a rule finalized in the last few weeks of the Obama administration.
Amid a legal challenge from several prominent hospital groups, the administration abruptly reversed course this week, assuring the plaintiffs and the court that the matter would soon be resolved to everyone’s satisfaction. The hospitals aren’t buying it.
At issue, the plaintiffs say, are regulations designed to protect hospitals from being overcharged by drug manufacturers. The delays are causing significant financial harm to the nearly 2,500 hospitals nationwide that participate in the 340B Drug Pricing Program, they allege.”